1,723 recalls
III
Sirolimus Tablets 1mg Tablets 100-count bottle, Rx Only, Distributed by: Dr.
Failed Impurities/Degradation Specifications
Dr. Reddy's Laboratories, Inc. · May 29, 2024
III
Xelpros (latanoprost ophthalmic emulsion) 0.005%, 125mcg/2.5mL, 2.5 mL bottle, Rx only, Manufactured by: Sun Pharmaceuti…
Failed Release Testing: Out of specification for particulate matter test.
Sun Pharmaceutical Industries Inc · May 29, 2024
III
Sodium Sulfacetamide 10% - Sulfur 5% Cleanser, Rx Only, 6 oz (170.3 g) Bottle, Manufactured for Acela Pharmaceuticals, L…
Subpotent drug
Acella Pharmaceuticals, LLC · May 15, 2024
III
Valacyclovir Tablets USP, 500 mg, 90 count bottles, Rx Only, Manufactured for: Mylan Pharmaceuticals Inc.
Failed Tablet/Capsule Specifications: There is a potential for the imprint, M 122, to be missing on some tablets.
Viatris Inc · May 8, 2024
III
Fentanyl 1000mcg/100mL (10mcg/mL) in 0.9% Sodium Chloride Injection, packaged in 100mL bags, Rx only, Compounded by: Hik…
Labeling: Wrong Barcode
Hikma Injectables USA Inc · May 8, 2024
III
Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free, 1 mL Single-Use vials, Rx only, Imprimis NJOF, LLC…
Out of specification for assay
Imprimis NJOF, LLC · May 8, 2024
III
Abilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 5…
Cross Contamination with Other Products
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. · May 1, 2024
III
Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 5…
Cross Contamination with Other Products
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. · May 1, 2024
III
Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (…
Cross Contamination with Other Products
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. · May 1, 2024
III
Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59…
Cross Contamination with Other Products
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. · May 1, 2024
III
Digoxin Tablets, USP 62.5 mcg (0.0625 mg), 100-count bottles, Rx Only, Manufactured by: Novitium Pharma LLC, 70 Lake Dri…
Failed Impurities/Degradation Specifications
Novitium Pharma LLC · Apr 24, 2024
III
NEXLIZET (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg, 30-count bottle, Rx only, Manufactured for: Esperion Ther…
Failed dissolution specifications: out-of-specification bempedoic acid dissolution at the 0-month timepoint.
Esperion · Apr 24, 2024
III
Cyclophosphamide for Injection, USP, 1g/vial, Lyophilized, Single Dose Vial, Discard unused solution, Cytotoxic Agent, A…
Labeling: Incorrect or missing Package Insert: There is an error on the Package Insert (PI), section 2.3, Preparation, H…
X-Gen Pharmaceuticals Inc. · Apr 10, 2024
III
Cyclophosphamide for Injection, USP, 500mg/vial, Lyophilized, Cytotoxic Agent, Single Dose Vial for Intravenous Use, Rx…
Labeling: Incorrect or missing Package Insert: There is an error on the Package Insert (PI), section 2.3, Preparation, H…
X-Gen Pharmaceuticals Inc. · Apr 10, 2024
III
Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake Driv…
Cross Contamination with Other Products:(mycophenolate mofetil).
Novitium Pharma LLC · Mar 27, 2024
III
Mercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b) 250-count bottle (NDC 69076-91…
Failed Dissolution Specifications: results slightly under spec at at 9-months.
Stason Pharmaceuticals, Inc. · Mar 13, 2024
III
Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Manufactured for: Glasshouse Pharmaceuticals Limited Canad…
Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.
Contract Pharmaceuticals Limited Canada · Mar 13, 2024
III
Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and Distributed by: Marlex Pharmaceuti…
Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.
Contract Pharmaceuticals Limited Canada · Mar 13, 2024
III
Nortrel 7/7/7 (norethindrone and ethinyl estradiol tablets USP- triphasic regimen), packaged in cartons, each carton con…
Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.
Teva Pharmaceuticals USA, Inc · Feb 21, 2024
III
Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons, each carton contains 3 blister ca…
Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.
Teva Pharmaceuticals USA, Inc · Feb 21, 2024